scholarly journals Budget Impact of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy: A US Commercial Health Plan Perspective

2018 ◽  
Vol 21 ◽  
pp. S193
Author(s):  
A Fu ◽  
D Taylor
2017 ◽  
Vol 20 (9) ◽  
pp. A641
Author(s):  
TB Gosden ◽  
J Dhanjal ◽  
D Arper ◽  
A Madoni ◽  
E Friggi

1997 ◽  
Vol 90 (Supplement) ◽  
pp. 10-11
Author(s):  
William J. Elliott

Sign in / Sign up

Export Citation Format

Share Document